US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 5.530
  • -0.090-1.60%
Close Mar 11 16:00 ET
  • 5.530
  • 0.0000.00%
Post 16:07 ET
300.48MMarket Cap-1.54P/E (TTM)

Emergent BioSolutions Key Stats

Emergent BioSolutions Q4 2024 Earnings Date

Currency:USDMar 3, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
254.67M
194.70M
-59.97M
Miss Est.
-7.93%
-29.61%
-23.55%
EPS
-0.25
-0.58
-0.33
Miss Est.
+73.73%
+38.95%
-132.46%
Buy

Feb 28, 2025

Emergent BioSolutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 194.000M--
--2025/Q1-- / 218.500M--
Mar 3, 20252024/Q4194.700M / 254.667M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 194.000M--
--2025/Q1-- / 218.500M--
Mar 3, 20252024/Q4194.700M / 254.667M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--

Unlock Free Earnings Estimates

Emergent BioSolutions Earnings Reports

Read more

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More